Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Verastem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Verastem Inc, Medical Devices Deals, 2012 to YTD 2018 10
Verastem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Verastem Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Verastem Acquires Patent Right to Inhibition of Focal Adhesion Kinase from Encarta 12
Verastem Acquires PI3K and mTOR from S*Bio 13
Partnerships 14
Merck Sharp & Dohme, Verastem and Cancer Research UK Enter into Agreement 14
Merck, Pfizer and Verastem Enter into Agreement 15
Verastem Enters Into Research Agreement With Eisai For Small Molecule Wnt Inhibitors 16
Licensing Agreements 17
CSPC Pharmaceutical Enters into Licensing Agreement with Verastem 17
Yakult Honsha Enters into Licensing Agreement with Verastem 18
Verastem Enters into Licensing Agreement with Infinity Pharma for Duvelisib 19
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 21
Verastem Enters into Licensing Agreement with Pfizer 23
Equity Offering 24
Verastem Plans to Raise Funds through Public Offering of Securities 24
Verastem to Raise USD43 Million in Public Offering of Shares 25
Verastem Raises USD40.2 Million in Public Offering Raise of Shares 26
Verastem Raises USD25 Million in Public Offering of Shares 28
Verastem Amends Public Offering of Shares for USD75 Million 29
Verastem USD54 Million in Public Offering of Shares 31
Verastem Raises USD35Million in Public Offering of Shares 33
Verastem Completes Public Offering Of Shares For US$63.8 Million 34
Verastem Completes IPO For US$63 Million 36
Debt Offering 38
Verastem Oncology Raises USD150 Million in Private Placement of 5% Notes Due 2048 38
Verastem Inc – Key Competitors 40
Verastem Inc – Key Employees 41
Verastem Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
Aug 08, 2018: Verastem Oncology reports second quarter 2018 financial results 43
May 03, 2018: Verastem Oncology Reports First Quarter 2018 Financial Results 46
Mar 13, 2018: Verastem Announces Year-End 2017 Financial Results 48
Nov 07, 2017: Verastem Reports Third Quarter 2017 Financial Results 50
Aug 08, 2017: Verastem Reports Second Quarter 2017 Financial Results 53
May 10, 2017: Verastem Reports First Quarter 2017 Financial Results 56
Mar 23, 2017: Verastem Reports Year-End 2016 Financial Results 58
Corporate Communications 60
Oct 18, 2018: Verastem Oncology announces executive leadership appointments and changes 60
Aug 29, 2018: Verastem Oncology names Robert E. Gagnon as chief financial officer 61
Jan 04, 2018: Verastem Appoints Joseph Lobacki as Chief Commercial Officer 62
Jul 11, 2017: Verastem Names Julie B. Feder As Chief Financial Officer 63
May 02, 2017: Verastem Appoints Eric K. Rowinsky to the Board of Directors 64
Legal and Regulatory 65
Jun 25, 2018: Verastem Oncology to join Russell 3000 index 65
Product News 66
10/11/2017: Verastem Appoints New CMO to Oversee Development of Cancer Drug Candidate Defactinib 66
Jul 25, 2017: Verastem Publishes Scientific Data Highlighting Potential Role Of FAK Inhibition In Pancreatic And Breast Cancer 67
07/25/2017: Verastem Publishes Scientific Data Highlighting Potential Role of FAK Inhibition in Pancreatic and Breast Cancer 69
01/26/2017: Verastem Announces Dosing of First Patient in Combination Trial of Defactinib and Avelumab in Patients with Ovarian Cancer 70
Clinical Trials 72
Apr 02, 2017: Data on Verastems Focal Adhesion Kinase Inhibitor Defactinib Presented at the 2017 American Association for Cancer Research Annual Meeting 72
Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73
Verastem Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Verastem Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Verastem Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Verastem Inc, Medical Devices Deals, 2012 to YTD 2018 10
Verastem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Verastem Acquires Patent Right to Inhibition of Focal Adhesion Kinase from Encarta 12
Verastem Acquires PI3K and mTOR from S*Bio 13
Merck Sharp & Dohme, Verastem and Cancer Research UK Enter into Agreement 14
Merck, Pfizer and Verastem Enter into Agreement 15
Verastem Enters Into Research Agreement With Eisai For Small Molecule Wnt Inhibitors 16
CSPC Pharmaceutical Enters into Licensing Agreement with Verastem 17
Yakult Honsha Enters into Licensing Agreement with Verastem 18
Verastem Enters into Licensing Agreement with Infinity Pharma for Duvelisib 19
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 21
Verastem Enters into Licensing Agreement with Pfizer 23
Verastem Plans to Raise Funds through Public Offering of Securities 24
Verastem to Raise USD43 Million in Public Offering of Shares 25
Verastem Raises USD40.2 Million in Public Offering Raise of Shares 26
Verastem Raises USD25 Million in Public Offering of Shares 28
Verastem Amends Public Offering of Shares for USD75 Million 29
Verastem USD54 Million in Public Offering of Shares 31
Verastem Raises USD35Million in Public Offering of Shares 33
Verastem Completes Public Offering Of Shares For US$63.8 Million 34
Verastem Completes IPO For US$63 Million 36
Verastem Oncology Raises USD150 Million in Private Placement of 5% Notes Due 2048 38
Verastem Inc, Key Competitors 40
Verastem Inc, Key Employees 41
Verastem Inc, Subsidiaries 42
List of Figures
Verastem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Verastem Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Verastem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Verastem Inc, Medical Devices Deals, 2012 to YTD 2018 10